Metraipolis › archive › dc_97eeff7efe3a

Harnessing the AI/ML in Drug and Biological Products Discovery and Development: The Regulatory Perspective — Europe PMC PMID:39861110

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/39861110
DOI: 10.3390/ph18010047
License (as archived): solo-consultazione
Archived: 2026-10-07T23:25:49.859Z
SHA-256 of the archived text: 9069a952cdc30d78394ec1b8d84d98f7eea976effbc118768c5e5fb288993907
Stable URL of this page: https://metraipolis.com/documento/dc_97eeff7efe3a

How to cite

Harnessing the AI/ML in Drug and Biological Products Discovery and Development: The Regulatory Perspective — Europe PMC PMID:39861110 — Europe PMC (en), https://europepmc.org/article/MED/39861110 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_97eeff7efe3a (Metraipolis archive dc_97eeff7efe3a, sha256 9069a952cdc30d78394ec1b8d84d98f7eea976effbc118768c5e5fb288993907)

BibTeX

@misc{dc97eeff7efe3a,
  title = {Harnessing the AI/ML in Drug and Biological Products Discovery and Development: The Regulatory Perspective — Europe PMC PMID:39861110},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/39861110},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_97eeff7efe3a; sha256 9069a952cdc30d78394ec1b8d84d98f7eea976effbc118768c5e5fb288993907},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39861110. Agents can read the archived copy with the MCP tool read_document.